Analysis of Potential Cinnamomum zeylanicum Blume Essential Oil Against Alzheimer's Disease: A Molecular Docking Study
Downloads
Background: Alzheimer's Disease (AD) is a neurodegenerative disorder with progressive impairment of behavioural and cognitive functions and the most common cause of dementia. The pathophysiology of AD is associated with low acetylcholine, accumulation of amyloid beta plaque, and neurofibrillary tangles in the brain. Cinnamomum zeylanicum is known to have many medicinal properties, especially neuroprotective effects. Objective: This research was designed to determine the neuroprotective potential of the phytochemicals C. zeylanicum using an in silico study. Methods: There are 5 phytochemicals compounds of C. zeylanicum used in this study. It's qualified for Lipinski's rules of five and can cross blood brain barrier. The protein targets were AChE, BACE1, and GSK-3. Molecular docking and visualization were performed using Avogadro, AutoDock 4.2 PyMol and Biovia Discovery Studio 2019. Results: In silico results show that the main phytochemical compounds of C. zeylanicum Blume essential oil have great potency as an AD drug. The best interaction model of the compound was shown by trans-cinnamyl acetate and coumaric acid. Although the binding energy of the compounds is lower than AD drugs (donepezil, rivastigmine, galantamine), the binding energy is not much different from rivastigmine and galantamine. Conclusion: The phytochemical compounds of C. zeylanicum Blume essential oil have an effect as a neuroprotective agent for AD and should be investigated in future research.
Alzheimer's Disease International and Alzheimer's Australia (2014) Dementia in the Asia Pacific Region, Alzheimer's Disease International. London: Alzheimer'ss Disease International. Available at: https://www.alz.co.uk/dementia-in-the-asia-pacific.
Bhat, R. et al. (2003) ‘Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418', Journal of Biological Chemistry, 278(46), pp. 45937–45945. doi: 10.1074/jbc.M306268200.
Cai, Z. M. et al. (2020) ‘1,8-Cineole: a review of source, biological activities, and application', Journal of Asian Natural Products Research. Taylor & Francis. doi: 10.1080/10286020.2020.1839432.
Cassani, R. et al. (2018) ‘Systematic review on resting-state EEG for Alzheimer's disease diagnosis and progression assessment', Disease Markers, 2018, pp. 1–26. doi: 10.1155/2018/5174815.
Cortes-Canteli, M. and Iadecola, C. (2020) ‘Alzheimer's Disease and Vascular Aging', Journal of the American College of Cardiology, 75(8), pp. 942–951. doi: 10.1016/j.jacc.2019.10.062.
Cumming, J. N. et al. (2012) ‘Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor', Bioorganic and Medicinal Chemistry Letters. Elsevier Ltd, 22, pp. 2444–2449. doi: 10.1016/j.bmcl.2012.02.013.
Dá Mesquita, S. et al. (2016) ‘Insights on the pathophysiology of Alzheimer's disease: The crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system', Neuroscience and Biobehavioral Reviews. Elsevier Ltd. doi: 10.1016/j.neubiorev.2016.06.014.
Dhage, P. A. et al. (2021) ‘Leveraging hallmark Alzheimer's molecular targets using phytoconstituents: Current perspective and emerging trends', Biomedicine and Pharmacotherapy. Elsevier Masson SAS, 139, pp. 1–16. doi: 10.1016/j.biopha.2021.111634.
Fahad, M. et al. (2018) ‘Medicinal and pharmacological role of traditional Asian Food condiment : Cinnamomum zeylanicum Blume', International Journal of Advances in Pharmacy Medicine and Bioallied Sciences, 6(1), pp. 22–30. Available at: http://biomedjournal.com/medicinal-and-pharmacological-role-of-traditional-asian-food-condiment-cinnamomum-zeylanicum-blume/.
Fan, L. et al. (2020) ‘New Insights Into the Pathogenesis of Alzheimer's Disease', Frontiers in Neurology, 10, pp. 1–12. doi: 10.3389/fneur.2019.01312.
Ferreira, P. S. et al. (2018) ‘A Review of Analytical Methods for p-Coumaric Acid in Plant-Based Products, Beverages, and Biological Matrices', Critical Reviews in Analytical Chemistry. Taylor & Francis. doi: 10.1080/10408347.2018.1459173.
Frydman-Marom, A. et al. (2011) ‘Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models', PLoS ONE, 6(1), pp. 1–11. doi: 10.1371/journal.pone.0016564.
Gnanaraj, C. et al. (2022) ‘In Silico Molecular Docking Analysis of Karanjin against Alzheimer's and Parkinson's Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy', Molecules, 27. doi: 10.3390/molecules27092834.
Hajinejad, M. et al. (2020) ‘Natural Cinnamaldehyde and Its Derivatives Ameliorate Neuroinflammatory Pathways in Neurodegenerative Diseases', BioMed Research International. doi: 10.1155/2020/1034325.
Hamidpour, R. et al. (2015) ‘Cinnamon from the selection of traditional applications to its novel effects on the inhibition of angiogenesis in cancer cells and prevention of Alzheimer's disease, and a series of functions such as antioxidant, anticholesterol, antidiabetes, antibacteri', Journal of Traditional and Complementary Medicine, 5, pp. 66–70. doi: 10.1016/j.jtcme.2014.11.008.
Jagust, W. (2018) ‘Imaging the evolution and pathophysiology of Alzheimer disease', Nature Reviews Neuroscience. Springer US, 19, pp. 687–700. doi: 10.1038/s41583-018-0067-3.
Kallel, I. et al. (2019) ‘Optimization of Cinnamon (Cinnamomum zeylanicum Blume) Essential Oil Extraction: Evaluation of Antioxidant and Antiproliferative Effects', Evidence-based Complementary and Alternative Medicine. Hindawi, 2019. doi: 10.1155/2019/6498347.
Kareti, S. R. and Pharm, S. M. (2020) ‘In Silico Molecular Docking Analysis of Potential Anti-Alzheimer's Compounds Present in Chloroform Extract of Carissa carandas Leaf Using Gas Chromatography MS/MS', Current Therapeutic Research. Elsevier Inc., 93. doi: 10.1016/j.curtheres.2020.100615.
Khaerunnisa, S., Suhartati and Awaluddin, R. (2020) Penelitian in silico untuk pemula. Surabaya: Airlangga University Press.
Khoshnazar, M., Parvardeh, S. and Bigdeli, M. R. (2020) ‘Alpha-pinene exerts neuroprotective effects via anti-inflammatory and anti-apoptotic mechanisms in a rat model of focal cerebral ischemia-reperfusion', Journal of Stroke and Cerebrovascular Diseases. Elsevier Inc., 29(8). doi: 10.1016/j.jstrokecerebrovasdis.2020.104977.
Kumar, A. et al. (2022) ‘Alzheimer Disease', in In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available at: https://www.ncbi.nlm.nih.gov/books/NBK499922/.
Kumar, Shivani, Chowdhury, S. and Kumar, Suresh (2017) ‘In silico repurposing of antipsychotic drugs for Alzheimer's disease', BMC Neuroscience. BioMed Central, 18(76), pp. 1–16. doi: 10.1186/s12868-017-0394-8.
Lipinski, C. A. et al. (2001) ‘Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings', 46, pp. 3–26. Available at: https://pubmed.ncbi.nlm.nih.gov/11259830/.
Litke, R. et al. (2021) ‘Modifiable Risk Factors in Alzheimer Disease and Related Dementias: A Review', Clinical Therapeutics. Elsevier Inc., 43(6), pp. 953–965. doi: 10.1016/j.clinthera.2021.05.006.
Long, J. M. and Holtzman, D. M. (2019) ‘Alzheimer Disease: An Update on Pathobiology and Treatment Strategies', Cell. Elsevier Inc., 179(3), pp. 312–339. doi: 10.1016/j.cell.2019.09.001.
Lucey, B. P. (2020) ‘It's complicated: The relationship between sleep and Alzheimer's disease in humans', Neurobiology of Disease. Elsevier, 144, pp. 1–8. doi: 10.1016/j.nbd.2020.105031.
Momtaz, S. et al. (2017) ‘Cinnamon, a promising prospect towards Alzheimer's disease', Pharmacological Research. Elsevier Ltd. doi: 10.1016/j.phrs.2017.12.011.
National Center for Biotechnology Information (2022a) ‘PubChem Compound Summary for CID 2758, Eucalyptol'. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Eucalyptol.
National Center for Biotechnology Information (2022b) ‘PubChem Compound Summary for CID 5282110, Cinnamyl acetate'. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Cinnamyl-acetate.
National Center for Biotechnology Information (2022c) ‘PubChem Compound Summary for CID 637511, Cinnamaldehyde'. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Cinnamaldehyde.
National Center for Biotechnology Information (2022d) ‘PubChem Compound Summary for CID 637542, 4-Hydroxycinnamic acid'. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/4-Hydroxycinnamic-acid.
National Center for Biotechnology Information (2022e) ‘PubChem Compound Summary for CID 6654, alpha-Pinene'. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/alpha-Pinene.
Ong, P. A. et al. (2021) ‘Dementia Prevalence, Comorbidities, and Lifestyle Among Jatinangor Elders', Frontiers in Neurology, 12. doi: 10.3389/fneur.2021.643480.
Pardridge, W. M. (2020) ‘Treatment of alzheimer's disease and blood–brain barrier drug delivery', Pharmaceuticals, 13, pp. 1–25. doi: 10.3390/ph13110394.
Rao, P. V. and Gan, S. H. (2014) ‘Cinnamon: A multifaceted medicinal plant', Evidence-based Complementary and Alternative Medicine, pp. 1–12. doi: 10.1155/2014/642942.
Samanta, S., Ramesh, M. and Govindaraju, H. (2022) ‘Chapter 1: Alzheimer's is a Multifactorial Disease', in Alzheimer's Disease: Recent Findings in Pathophysiology, Diagnostic and Therapeutic Modalities, pp. 1–34. doi: 10.1039/9781839162732-00001.
Tepe, A. S. and Ozaslan, M. (2020) ‘Anti-Alzheimer, anti-diabetic, skin-whitening, and antioxidant activities of the essential oil of Cinnamomum zeylanicum', Industrial Crops and Products. Elsevier, 145, pp. 1–8. doi: 10.1016/j.indcrop.2019.112069.
Tiwari, S. et al. (2019) ‘Alzheimer ' s disease: pathogenesis, diagnostics and therapeutics', International Journal of Nanomedicine, Jul 2019(14), pp. 5541–5554. doi: 10.2147/IJN.S200490.
Trang, A. and Khandhar, P. B. (2022) ‘Physiology, Acetylcholinesterase', in StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available at: https://www.ncbi.nlm.nih.gov/books/NBK539735/.
Vinicius, M. et al. (2019) ‘Alzheimer's disease: risk factors and potentially protective measures', Journal of Biomedical Scienceedical Science. Journal of Biomedical Science, 26(33), pp. 1–11. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507104/.
Wang, J. et al. (2020) ‘Traditional uses, phytochemistry and pharmacological activities of the genus Cinnamomum (Lauraceae): A review', Fitoterapia. Elsevier, 146. doi: 10.1016/j.fitote.2020.104675.
Yiannopoulou, K. G. and Papageorgiou, S. G. (2020) ‘Current and Future Treatments in Alzheimer Disease: An Update', Journal of Central Nervous System Disease, 12, pp. 1–12. doi: 10.1177/1179573520907397.
Zhang, L. et al. (2015) ‘Research progress of trans-cinnamaldehyde pharmacological effects', China Journal of Chinese Materia Medica, 40(23), pp. 4568–4572. Available at: https://pubmed.ncbi.nlm.nih.gov/27141665/.
Copyright (c) 2023 JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. The copyright of this journal belongs to the Editorial Board and Journal Manager with the author's knowledge, while the moral right of the publication belong to the author.
2. The formal legal aspect of journal publication accessibility refers to the Creative Commons Attribution-Non-Commercial-Share Alike (CC BY-NC-SA), which implies that the publication can be used for non-commercial purposes in its original form.
3. Every publication (print/electronic) is open access for educational, research, and library purposes. In addition to the objectives mentioned above, the editorial board is not responsible for copyright infringement
.jpg)
